BioSpace News Archive

Press Releases

Vaxcyte Reports Positive Topline Data from OPUS-1, the Pivotal Adult Phase 3 Trial of VAX-31, the Company’s 31-Valent Pneumococcal Conjugate Vaccine Candidate

October 5, 2026
·
17 min read
Press Releases

Energenesis Biomedical and Yoo Young Pharm Sign MOU for ENERGI-F703DFU Development and Commercialization in Korea

October 5, 2026
·
2 min read
Press Releases

West to Highlight Industry Leadership in Packaging and Containment at CPHI Worldwide

October 5, 2026
·
2 min read
Press Releases

HanchorBio Announces U.S. FDA Clearance of IND Application for HCB303, a Next-Generation Trispecific Immunotherapy

October 5, 2026
·
4 min read
Press Releases

Fortrea Announces Date for Third Quarter 2026 Financial Results and Conference Call

October 5, 2026
·
1 min read
Press Releases

Real-World Analysis Highlighting HAE Disease Experience and Gaps in Treatment Satisfaction Published in Advances in Therapy

October 5, 2026
·
8 min read
Press Releases

Alterity Therapeutics Presents New Analyses of ATH434 Phase 2 Data in Multiple System Atrophy at the 2026 International Congress of Parkinson’s Disease and Movement Disorders

October 5, 2026
·
8 min read
Press Releases

Invivyd Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - October 5, 2026

October 5, 2026
·
1 min read
Press Releases

Nurix Therapeutics Announces Second Research Term Extension for Oncology Program Under Collaboration with Gilead Sciences

October 5, 2026
·
6 min read
Press Releases

Harrow Closes Acquisition of TYRVAYA®

October 5, 2026
·
9 min read